Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Hall

Showing results (341-350 of 536) with videos related to

Pageof 54
Sort By:
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
Breast Cancer Research : BCR|August 16, 2015
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic densityAnja Rudolph, Peter A Fasching, Sabine Behrens, et al.
Breast Cancer Research : BCR|October 8, 2016
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumTaru A Muranen, Carl Blomqvist, Thilo Dörk, et al.
Breast Cancer Research : BCR|November 24, 2022
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patientsDaniele Giardiello, Maartje J Hooning, Michael Hauptmann, et al.
Oncotarget|April 1, 2015
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsRainer Fagerholm, Marjanka K Schmidt, Sofia Khan, et al.
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
International Journal of Cancer|July 4, 2017
Gene-environment interactions involving functional variants: Results from the Breast Cancer Association ConsortiumMyrto Barrdahl, Anja Rudolph, John L Hopper, et al.
Endocrine-Related Cancer|October 2, 2013
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction studyAnja Rudolph, Rebecca Hein, Sara Lindström, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Nature Communications|September 10, 2015
Corrigendum: genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer riskSara Lindström, Deborah J Thompson, Andrew D Paterson, et al.
Pageof 54

Showing results (341-350 of 536) with videos related to

Sort By:
Pageof 54
BMC Cancer|December 18, 2015
A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patientsPetra Seibold, Peter Schmezer, Sabine Behrens, et al.
Breast Cancer Research : BCR|August 16, 2015
A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic densityAnja Rudolph, Peter A Fasching, Sabine Behrens, et al.
Breast Cancer Research : BCR|October 8, 2016
Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association ConsortiumTaru A Muranen, Carl Blomqvist, Thilo Dörk, et al.
Breast Cancer Research : BCR|November 24, 2022
Correction: PredictCBC-2.0: a contralateral breast cancer risk prediction model developed and validated in ~ 200,000 patientsDaniele Giardiello, Maartje J Hooning, Michael Hauptmann, et al.
Oncotarget|April 1, 2015
The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patientsRainer Fagerholm, Marjanka K Schmidt, Sofia Khan, et al.
European Journal of Epidemiology|October 3, 2023
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancerKatharina Wichert, Reiner Hoppe, Katja Ickstadt, et al.
International Journal of Cancer|July 4, 2017
Gene-environment interactions involving functional variants: Results from the Breast Cancer Association ConsortiumMyrto Barrdahl, Anja Rudolph, John L Hopper, et al.
Endocrine-Related Cancer|October 2, 2013
Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction studyAnja Rudolph, Rebecca Hein, Sara Lindström, et al.
Oncotarget|February 10, 2017
TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerRainer Fagerholm, Sofia Khan, Marjanka K Schmidt, et al.
Nature Communications|September 10, 2015
Corrigendum: genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer riskSara Lindström, Deborah J Thompson, Andrew D Paterson, et al.
Pageof 54